Fidelity International’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.85M Sell
122,049
-191,461
-61% -$8.39M ﹤0.01% 666
2025
Q4
$12.1M Buy
313,510
+112,150
+56% +$4.28M 0.01% 558
2025
Q3
$7.1M Buy
201,360
+154,800
+332% +$5.6M 0.01% 610
2025
Q2
$1.68M Buy
46,560
+2,720
+6% +$90.1K ﹤0.01% 709
2025
Q1
$1.36M Sell
43,840
-4,856
-10% -$154K ﹤0.01% 705
2024
Q4
$1.24M Sell
48,696
-3,242
-6% -$86K ﹤0.01% 714
2024
Q3
$1.47M Buy
51,938
+5,319
+11% +$147K ﹤0.01% 706
2024
Q2
$1.23M Buy
46,619
+23,638
+103% +$655K ﹤0.01% 717
2024
Q1
$698K Buy
22,981
+1,621
+8% +$47.8K ﹤0.01% 743
2023
Q4
$600K Buy
21,360
+1,599
+8% +$43.9K ﹤0.01% 729
2023
Q3
$536K Buy
19,761
+1,816
+10% +$53.9K ﹤0.01% 718
2023
Q2
$552K Sell
17,945
-1,361
-7% -$46.1K ﹤0.01% 713
2023
Q1
$696K Buy
19,306
+11,406
+144% +$423K ﹤0.01% 731
2022
Q4
$312K Buy
+7,900
New +$330K ﹤0.01% 748

Other funds holding RPRX